Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-02-10 15:19 Tx date 2022-02-10 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+300,000 vol |
350,000 | |
Filed 2021-10-07 14:25 Tx date 2021-10-06 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+900,000 vol |
900,000 | |
Filed 2021-10-07 14:24 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-13 17:28 Tx date 2021-05-14 |
$ALPA
Alpha Esports Tech Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+100,000 vol |
100,000 | |
Filed 2021-07-13 17:23 Tx date 2021-05-10 |
$ALPA
Alpha Esports Tech Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-10 18:30 Tx date 2021-05-10 |
$
Alpha Esports Tech Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
Filed 2021-02-09 20:13 Tx date 2020-10-11 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+50,000 vol |
50,000 | |
Filed 2021-02-09 20:12 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-09-14 13:29 Tx date 2020-09-10 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
Filed 2020-09-14 13:28 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|